Fermer le menu




The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development.


RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

Lyonbiopole’s SMEs that have raised less than 2m to date can benefit from a registration reduction code.

Register here for 2-day virtual registration January 11-12th (Save $300) resulting in $895 

Register here for 3-day registration January 10-12th (50% off) resulting in $1,148

Contact Olivier Szymkowiak to get it!


Votre contact à Lyonbiopôle

Olivier Szymkowiak

Directeur des programmes stratégie & Financement